Skip to main content

Market Overview

AstraZeneca, EU Reach Settlement On COVID-19 Vaccine Delivery

AstraZeneca, EU Reach Settlement On COVID-19 Vaccine Delivery
  • AstraZeneca Plc (NASDAQ: AZN) and the European Commission have settled on the delivery of pending COVID-19 vaccine doses by the Company.
  • The agreement ends legal proceedings over the execution of the Advance Purchase Agreement.
  • Brussels had initiated legal proceedings against AstraZeneca in April. Court hearings were scheduled for the end of September 2021.
  • Related: AstraZeneca Can Face Legal Action Over Vaccine Shortfalls To EU.
  • AstraZeneca will deliver 60 million doses of its vaccine, Vaxzevria, by the end of Q3 of 2021, 75 million by the end of Q4 of 2021, and 65 million by the end of Q1 2022.
  • The EU's executive body said that member states would be provided with regular delivery schedules under the new agreement. If there were any delayed doses, capped rebates would be applied.
  • Price Action: AZN stock closed 1.48% higher at $59.59 on Thursday.

Related Articles (AZN + AZNCF)

View Comments and Join the Discussion!

Posted-In: Briefs COVID-19 CoronavirusBiotech Government News Health Care Contracts General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at